Topic: How To Invest

Hi, Pat: I would appreciate your thoughts on a company called RepliCel Life Sciences. Thanks in advance.

Article Excerpt

RepliCel Life Sciences Inc., $0.34, symbol RP on Toronto (Shares outstanding: 54.9 million; Market cap: $18.7 million; www.replicel.com), aims to develop and patent its hair-loss treatment. RepliCel’s technology uses cells taken from each patient’s own healthy hair follicles to reproduce and “reintroduce” cells to the affected areas. RepliCel also believes it can use its technology to treat a variety of issues that stem from cell deficiencies, including chronic tendinosis and aging skin. In late 2013, Shiseido Company, a major Japanese hair care and cosmetics firm, paid RepliCel $4.1 million for an exclusive licence to its RCH-01 male pattern baldness cell therapy in certain Asian countries, including Japan, China and South Korea. RepliCel is using up its cash at a rate of about $1 million per quarter. As of June 30, 2014, it held cash of $4.3 million, so it has enough to keep developing its therapies. The company has completed a Phase I trial on RCH-01 and is now aiming to start a Phase…